1. Home
  2. BUUU vs BRNS Comparison

BUUU vs BRNS Comparison

Compare BUUU & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BUUU
  • BRNS
  • Stock Information
  • Founded
  • BUUU 2017
  • BRNS 2016
  • Country
  • BUUU Hong Kong
  • BRNS United Kingdom
  • Employees
  • BUUU N/A
  • BRNS N/A
  • Industry
  • BUUU Services-Misc. Amusement & Recreation
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BUUU Consumer Discretionary
  • BRNS Health Care
  • Exchange
  • BUUU Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • BUUU 68.1M
  • BRNS 58.0M
  • IPO Year
  • BUUU 2025
  • BRNS 2021
  • Fundamental
  • Price
  • BUUU $8.54
  • BRNS $1.45
  • Analyst Decision
  • BUUU
  • BRNS Strong Buy
  • Analyst Count
  • BUUU 0
  • BRNS 1
  • Target Price
  • BUUU N/A
  • BRNS $3.00
  • AVG Volume (30 Days)
  • BUUU 37.3K
  • BRNS 243.1K
  • Earning Date
  • BUUU 01-01-0001
  • BRNS 11-05-2025
  • Dividend Yield
  • BUUU N/A
  • BRNS N/A
  • EPS Growth
  • BUUU N/A
  • BRNS N/A
  • EPS
  • BUUU 0.04
  • BRNS N/A
  • Revenue
  • BUUU $5,754,120.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • BUUU N/A
  • BRNS N/A
  • Revenue Next Year
  • BUUU N/A
  • BRNS N/A
  • P/E Ratio
  • BUUU $221.56
  • BRNS N/A
  • Revenue Growth
  • BUUU 64.23
  • BRNS 1766.46
  • 52 Week Low
  • BUUU $3.67
  • BRNS $0.64
  • 52 Week High
  • BUUU $9.50
  • BRNS $2.92
  • Technical
  • Relative Strength Index (RSI)
  • BUUU N/A
  • BRNS 59.48
  • Support Level
  • BUUU N/A
  • BRNS $1.06
  • Resistance Level
  • BUUU N/A
  • BRNS $1.67
  • Average True Range (ATR)
  • BUUU 0.00
  • BRNS 0.16
  • MACD
  • BUUU 0.00
  • BRNS 0.04
  • Stochastic Oscillator
  • BUUU 0.00
  • BRNS 66.97

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: